Wayne Goodman, MD
Department of Psychiatry, McKnight Brain Institute at the University of Florida
Dr. Wayne Goodman was raised in New York City where he attended the Bronx High School of Science. He graduated from Columbia University with a degree in Electrical Engineering and received his Medical Degree from Boston University. Dr. Goodman completed his internship, residency, and a research fellowship at Yale University School of Medicine where he rose to the rank of Associate Professor of Psychiatry.
In 1985, he founded and served as chief of the Obsessive Compulsive Disorders Clinic at Yale's prestigious Clinical Neuroscience Research Unit. While on faculty at Yale, he conducted research on the phenomenology, neurobiology, and treatment of obsessive-compulsive disorder (OCD), Tourette's Syndrome and Anxiety Disorders. He is the principal developer of the Y-BOCS, the gold standard for rating OCD, and conducted some of the first controlled trials of selective serotonin reuptake inhibitors in OCD. Additionally, Dr. Goodman was the co-founder of the Obsessive Compulsive Foundation, today's major consumer advocacy organization for this disorder, and served as Chair of its Scientific Advisory Board from 1986-1996.
Dr. Goodman joined the University of Florida College of Medicine as Professor of Psychiatry in 1993 and was appointed Department Chairman in July 1998. Dr. Goodman has over 200 publications, is listed among the Mostly Highly Cited researchers in Psychiatry/Psychology, was named as one of the "Best Doctors" in 2005-6, and holds several grants from NIMH including a study of Deep Brain Stimulation in refractory OCD and another on PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Strep). Dr. Goodman is a member of the ACNP (American College of Neuropharmacology), the Alpha-Omega-Alpha medical honor society, and NIMH Study Section. He is chair of the FDA's Psychopharmacology Advisory Committee. In addition to being a member of the Byrd Alzheimer's Research Center Board of Directors, he is active at the state level as a member of the Governor's Task Force on Suicide Prevention.